Skierniewice, Poland

Velocity Clinical Research, Skierniewice

Velocity Clinical Research's site in Skierniewice, Poland, was established in 2000 as ClinMedica Research and acquired by Velocity in 2023. As the largest clinical research facility in the region, the site specializes in conducting Phase II-IV clinical trials across a wide range of therapeutic areas, including cardiology, dermatology, pulmonology, endocrinology, metabolic diseases, gastroenterology, and population-based vaccine studies.

Recognized for its strong reputation and exceptional patient care, Velocity Skierniewice is highly regarded by sponsors and contract research organizations (CROs). The site maintains close ties with Ogrodowa Medical Center and local communities, allowing for fast and accurate patient recruitment, even for diverse populations. With a commitment to advancing medicine through research, the Skierniewice team combines decades of experience with high-quality, compassionate patient care to support a broad array of clinical studies.

Velocity Clinical Research, Skierniewice
Ogrodowa 21/23 1 piętro, Skierniewice, Poland 96-100

Phone: +48 692 806 434

Find a Clinical Trial in Skierniewice
Browse current research studies in Skierniewice on VelocityClinicalTrials.eu.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Skierniewice

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Skierniewice is dedicated to conducting quality research in a professional and caring environment.

  • Grzegorz Kania, MD

    Grzegorz Kania, MD

    Principal Investigator
    Grzegorz Kania, MD specializes in cardiology as well as internal and family medicine. In 2000, he founded Centrum Medyczne Ogrodowa, which is the largest outpatient clinic in Skierniewice, Poland, before he founded ClinMedica Research in 2016 as a dedicated research center. He has been a co-investigator and principal investigator in approximately 300 clinical trials in the field of cardiology and internal diseases.

    Published in several medical journals, his work has contributed to some of the most recent academic thinking on cardiovascular treatments. He holds a medical degree from the Medical University of Lodz and did postgraduate studies in clinical research management at the Medical University of Lublin. His wife and two daughters are also in the medical field.

  • Maciej Kania, MD

    Principal Investigator, Site Director

  • Małgorzata Zalewska, MD

    Principal Investigator

  • Jacek Stachera, MD

    Principal Investigator

  • Bożena Kucińska, MD

    Principal Investigator

  • Joanna Kania, MD

    Principal Investigator

  • Agnieszka Kucińska, MD

    Principal Investigator

  • Witold Chrustowski, MD

    Principal Investigator

  • Dariusz Jastrzębski, MD

    Principal Investigator

  • Witold Urban, MD

    Principal Investigator

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.